Large language models (LLMs) are rapidly advancing medical artificial intelligence, offering revolutionary changes in health care. These models excel in natural language processing (NLP), enhancing clinical support, diagnosis, treatment, and medical research. Breakthroughs, like GPT-4 and BERT (Bidirectional Encoder Representations from Transformer), demonstrate LLMs’ evolution through improved computing power and data. However, their high hardware requirements are being addressed through technological advancements. LLMs are unique in processing multimodal data, thereby improving emergency, elder care, and digital medical procedures. Challenges include ensuring their empirical reliability, addressing ethical and societal implications, especially data privacy, and mitigating biases while maintaining privacy and accountability. The paper emphasizes the need for human-centric, bias-free LLMs for personalized medicine and advocates for equitable development and access. LLMs hold promise for transformative impacts in health care.
22 August 2024 in Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies
The electrocardiogram (ECG) has always served as a crucial biomedical examination for cardiac diseases monitoring and diagnosing. Typical ECG measurement requires attaching electrodes to the body, which is inconvenient for long-term monitoring. Recent wireless sensing maps wireless signals reflected from human chest into electrical activities of heart so as to reconstruct ECG contactlessly. While making great progress, we find existing works are effective only for healthy populations with normal ECG, but fall short when confronted with the most desired usage scenario: reconstructing ECG accurately for people with cardiac diseases such as atrial fibrillation, premature ventricular beat. To bridge the gap, we propose AirECG, which moves forward to reconstruct ECG for both healthy people and even cardiac patients with morbid ECG, i.e., irregular rhythm and anomalous ECG waveform, via contactless millimeter-wave sensing. To realize AirECG, we first custom-design a cross-domain diffusion model that can perform multiple iteration denoising inference, in contrast with the single-step generative models widely used in previous works. In this way, AirECG is able to identify and eliminate the distortion due to the unstable and irregular cardiac activities, so as to synthesize ECG even during abnormal beats. Furthermore, we enhance the determinacy of AirECG, i.e., to generate high-fidelity ECG, by designing a calibration guidance mechanism to combat the inherent randomness issue of the probabilistic diffusion model. Empirical evaluation demonstrates AirECG's ability of ECG synthesis with Pearson correlation coefficient (PCC) of 0.955 for normal beats. Especially for abnormal beats, the PCC still exhibits a strong correlation of 0.860, with 15.0%~21.1% improvement compared with state-of-the-art approaches.
Cuff-less methods, especially pulse wave analysis (PWA) techniques with PPG/mmWave sensing, have shown great potential for non-intrusive blood pressure (BP) monitoring. However, the state-of-the-art solutions are only validated on small-scale healthy subjects, neglecting patients with abnormal BP and thus a more urgent need for BP monitoring. To bridge the gap, we first build the largest mmWave-BP dataset to our knowledge, including 930 real patients with cardiovascular diseases, and perform extensive experiments, which reveals that all existing PWA methods exhibit far less satisfactory performance with standard deviation errors (STD) exceeding 16 mmHg for systolic BP (SBP) and 11mmHg for diastolic BP (DBP). An in-depth investigation shows that physiological factors have complex effect on vascular elasticity and structure, thus people with very different BP values may exhibit extremely similar pulse waveform, which leads to confusion in model learning. In this work, we propose BP3, which fuses physiological factors into sensing-data-driven deep-learning framework, so as to capture the intricate effect of physiological factors during the whole process of learning pulse waveforms. Evaluation results show that BP3 achieves the mean errors of-1.57 mmHg and -0.34 mmHg, STD of 9.77 mmHg and 7.93 mmHg for SBP and DBP, respectively. Moreover importantly, BP3 shows remarkable gain particularly for subjects with abnormal BP, achieving mean errors that are only 0.48% ~ 20.86% of the state-of-the-art solutions.
The utilization of wearable devices with integrated photoplethysmography (PPG) sensors for continuous and comfortable Arterial Blood Pressure (ABP) monitoring has gained popularity. However, our analysis on a large-scale self-collected dataset reveals a significant challenge: approximately 56.7% of individuals experience the absence of the dicrotic notch (a vital morphology feature) in wrist-PPG data, while 23.8% face the same issue in finger-PPG data, which poses a big obstacle to generalized ABP monitoring. To address this challenge, we propose a morphology-independent ABP estimation algorithm based on the Frank-Starling law. We also devise techniques to address calibration and PPG data drift issues commonly faced in continuous ABP monitoring. Further, a system called RingBP is developed towards continuous, comfortable, and generalized ABP monitoring using a smart ring. We design and implement a smart ring prototype and conduct extensive experiments involving 85 participants, demonstrating its superiority over other solutions.
6 October 2021 in The Anatolian Journal of Cardiology
Presently, an effective model to predict long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy (HOCM) is lacking. Therefore, the objective of this study was to evaluate the predictive value of the modified Age, Creatinine clearance, and Ejection Fraction (mACEF) score for long-term cardiac mortality in patients with HOCM. Two hundred and ninety two patients with HOCM treated non-invasively were enrolled in this study, all of whom had intact medical information. Over a median follow-up period of 41.9 months, 28 cardiac deaths occurred. In univariate Cox regression analysis, the mACEF score was associated with long-term cardiac death [hazard ratio (HR)=1.795, 95% confidence interval (CI) 1.518–2.124, p<0.001]. Multiple Cox regression analysis identified the mACEF score as an independent risk factor for long-term cardiac death (adjusted HR=1.372, 95% CI 1.076–1.749, p=0.011). Analysis of the receiver operating characteristic (ROC) for long-term cardiac death showed that the mACEF score had a considerable predictive value (area under ROC 0.844, sensitivity 89.29%, specificity 75.00%) with an optimum cut-off value of 0.96. The study population was divided into high-risk (mACEF score ≥0.96, n=91) and low-risk (mACEF score <0.96, n=201) groups according to the optimum cut-off value. Kaplan-Meier survival analysis was performed and showed a dramatic higher rate of long-term cardiac mortality in the high-risk group than in the low-risk group (27.4% vs. 1.7%, p<0.001 by log-rank test). The mACEF score has a considerable predictive value for long-term cardiac mortality in patients with HOCM treated non-invasively. A mACEF score ≥0.96 could be considered as a sign of poor prognosis in patients with HOCM.